Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Clinical Judgment
100%
Heart Failure Management
100%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
100%
Clinical Evaluation
60%
New York Heart Association Class
60%
Comorbidity
40%
Patient Characteristics
40%
Clinical Symptoms
40%
Clinical Signs
40%
New York Heart Association Classification
40%
Jugular Vein
20%
Edema
20%
Serum Levels
20%
Body Mass Index
20%
Cystatin C (Cys C)
20%
Anemia
20%
High-sensitivity C-reactive Protein (hs-CRP)
20%
Hs-cTnT
20%
Clinical Assessment
20%
New York Heart Association
20%
Distension
20%
Guided Therapy
20%
Growth Differentiation factor-15 (GDF-15)
20%
Clinical Biomarkers
20%
Measurement Evaluation
20%
Heart Failure Biomarkers
20%
Orthopnoea
20%
Patient Comorbidities
20%
INIS
biological markers
100%
management
100%
heart failure
100%
new york
85%
patients
57%
symptoms
57%
evaluation
42%
classification
28%
levels
14%
therapy
14%
correlations
14%
comparative evaluations
14%
veins
14%
assessments
14%
concentration
14%
range
14%
edema
14%
anemias
14%
tnt
14%
Nursing and Health Professions
Outpatient
100%
Clinical Judgment
100%
Biological Marker
100%
Congestive Heart Failure
100%
New York Heart Association Class
71%
Clinical Evaluation
42%
Comorbidity
42%
Physical Disease by Body Function
28%
Blood Level
14%
Body Mass
14%
Clinical Assessment
14%
Edema
14%
Post Hoc Analysis
14%
Anemia
14%
Cystatin C
14%
Growth Differentiation Factor 15
14%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Congestive Heart Failure
100%
Clinical Trial
42%
Comorbidity
42%
Physical Disease by Body Function
28%
Anemia
14%
Cystatin C
14%
Edema
14%
Growth Differentiation Factor 15
14%